BDBM50373911 CHEMBL410705

SMILES: CCc1ccc(cc1)-c1nc(CCCC[C@H]2CO[C@](C)(OC2)C(O)=O)c(C)o1

InChI Key: InChIKey=IWKMXHIFDGSHAC-LMTLIKQPSA-N

Data: 2 EC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50373911   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Peroxisome proliferator-activated receptor (Homo sapiens (Human))	BDBM50373911 (CHEMBL410705) Show SMILES CCc1ccc(cc1)-c1nc(CCCC[C@H]2CO[C@](C)(OC2)C(O)=O)c(C)o1 |wU:15.15,18.23,wD:18.19,(8.46,-12.81,;9.24,-11.48,;10.78,-11.49,;11.56,-10.17,;13.09,-10.17,;13.85,-11.5,;13.08,-12.83,;11.54,-12.83,;15.39,-11.49,;16.3,-12.74,;17.76,-12.27,;19.01,-13.17,;20.41,-12.55,;21.66,-13.46,;23.07,-12.83,;24.31,-13.74,;25.71,-13.11,;26.95,-14.02,;26.79,-15.56,;27.18,-17.04,;25.37,-16.17,;24.14,-15.27,;28.26,-15.15,;29.36,-16.22,;28.65,-13.66,;17.76,-10.73,;19.01,-9.82,;16.3,-10.25,)| Show InChI InChI=1S/C22H29NO5/c1-4-16-9-11-18(12-10-16)20-23-19(15(2)28-20)8-6-5-7-17-13-26-22(3,21(24)25)27-14-17/h9-12,17H,4-8,13-14H2,1-3H3,(H,24,25)/t17-,22+	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	3.00E+3	n/a	n/a	n/a	n/a
Nippon Shinyaku Co., Ltd Curated by ChEMBL					Assay Description Agonist activity at human PPARgamma expressed in CV1 cells by transactivation assay				Bioorg Med Chem 16: 981-94 (2008) Article DOI: 10.1016/j.bmc.2007.10.007 BindingDB Entry DOI: 10.7270/Q2862H95
					More data for this Ligand-Target Pair
Peroxisome proliferator-activated receptor alpha (PPAR alpha) (Homo sapiens (Human))	BDBM50373911 (CHEMBL410705) Show SMILES CCc1ccc(cc1)-c1nc(CCCC[C@H]2CO[C@](C)(OC2)C(O)=O)c(C)o1 |wU:15.15,18.23,wD:18.19,(8.46,-12.81,;9.24,-11.48,;10.78,-11.49,;11.56,-10.17,;13.09,-10.17,;13.85,-11.5,;13.08,-12.83,;11.54,-12.83,;15.39,-11.49,;16.3,-12.74,;17.76,-12.27,;19.01,-13.17,;20.41,-12.55,;21.66,-13.46,;23.07,-12.83,;24.31,-13.74,;25.71,-13.11,;26.95,-14.02,;26.79,-15.56,;27.18,-17.04,;25.37,-16.17,;24.14,-15.27,;28.26,-15.15,;29.36,-16.22,;28.65,-13.66,;17.76,-10.73,;19.01,-9.82,;16.3,-10.25,)| Show InChI InChI=1S/C22H29NO5/c1-4-16-9-11-18(12-10-16)20-23-19(15(2)28-20)8-6-5-7-17-13-26-22(3,21(24)25)27-14-17/h9-12,17H,4-8,13-14H2,1-3H3,(H,24,25)/t17-,22+	PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	10	n/a	n/a	n/a	n/a
Nippon Shinyaku Co., Ltd Curated by ChEMBL					Assay Description Agonist activity at human PPARalpha expressed in CV1 cells by transactivation assay				Bioorg Med Chem 16: 981-94 (2008) Article DOI: 10.1016/j.bmc.2007.10.007 BindingDB Entry DOI: 10.7270/Q2862H95
					More data for this Ligand-Target Pair